0001914060-26-000001.txt : 20260603 0001914060-26-000001.hdr.sgml : 20260603 20260603162116 ACCESSION NUMBER: 0001914060-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 EFFECTIVENESS DATE: 20260603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biolexis Therapeutics Inc. CENTRAL INDEX KEY: 0001914060 ORGANIZATION NAME: EIN: 872356131 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586088 FILM NUMBER: 261060941 BUSINESS ADDRESS: STREET 1: 3900 N TRAVERSE MOUNTAIN BLVD STREET 2: SUITE 200 CITY: LEHI STATE: UT ZIP: 84043 BUSINESS PHONE: 801-550-8088 MAIL ADDRESS: STREET 1: 3900 N TRAVERSE MOUNTAIN BLVD STREET 2: SUITE 200 CITY: LEHI STATE: UT ZIP: 84043 FORMER COMPANY: FORMER CONFORMED NAME: Biolexis Therapeutics, Inc. DATE OF NAME CHANGE: 20220228 D 1 primary_doc.xml X0708 D LIVE 0001914060 Biolexis Therapeutics Inc. 3900 N TRAVERSE MOUNTAIN BLVD SUITE 200 LEHI UT UTAH 84043 801-328-3600 DELAWARE Biolexis Therapeutics, Inc. Corporation true 2021 Tyler Hartmann 3900 N Traverse Mountain Blvd. Suite 200 Lehi UT UTAH 84043 Executive Officer David J. Bearss 3900 N Traverse Mountain Blvd. Suite 200 Lehi UT UTAH 84043 Director Hariprasad Vankayalapati 3900 N Traverse Mountain Blvd. Suite 200 Lehi UT UTAH 84043 Director James N. Clarke 3900 N Traverse Mountain Blvd. Suite 200 Lehi UT UTAH 84043 Director Anthony Steve 3900 N Traverse Mountain Blvd. Suite 200 Lehi UT UTAH 84043 Director Biotechnology Decline to Disclose 06b false 2026-05-20 false true Convertible Promissory Notes false 0 12000000 1600000 10400000 false 2 0 0 0 false Biolexis Therapeutics Inc. Tyler Hartmann Tyler Hartmann President 2026-06-03